Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency

Background: medication-assisted treatment (MAT) with buprenorphine is now widely prescribed to treat addiction to heroin and other illicit opioids. There is some evidence that illicit opioids enhance HIV-1 replication and accelerate AIDS pathogenesis, but the effect of buprenorphine is unknown. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Gornalusse, Germán Gustavo, Vojtech, Lucia N., Levy, Claire N., Hughes, Sean M., Kim, Yeseul, Valdez, Rogelio, Pandey, Urvashi, Ochsenbauer, Christina, Astronomo, Rena, McElrath, Julie, Hladik, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402857/
https://www.ncbi.nlm.nih.gov/pubmed/34452338
http://dx.doi.org/10.3390/v13081472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402857/
https://www.ncbi.nlm.nih.gov/pubmed/34452338
http://dx.doi.org/10.3390/v13081472

Ejemplares similares